J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C, MacCallum P, Kakkar A, Hobbs FDR, Petrou S, Dale J, Poole CJ, Maraveyas A, Levine M. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). J Clin Oncol. 2018 Jul 10;36(20):2017-2023. \[[PubMed: 29746227](https://pubmed.ncbi.nlm.nih.gov/29746227)\] 40. Boon GJAM, Van Dam LF, Klok FA, Huisman MV. Management and treatment of deep vein thrombosis in special populations. Expert Rev Hematol. 2018 Sep;11(9):685-695. \[[PubMed: 30016119](https://pubmed.ncbi.nlm.nih.gov/30016119)\] 41. Ha NB, Regal RE. Anticoagulation in Patients With Cirrhosis: Caught Between a Rock-Liver and a Hard Place. Ann Pharmacother. 2016 May;50(5):402-9. \[[PubMed: 26861989](https://pubmed.ncbi.nlm.nih.gov/26861989)\] 42. Kruger PC, Eikelboom JW, Douketis JD, Hankey GJ. Deep vein thrombosis: update on diagnosis and management. Med J Aust. 2019 Jun;210(11):516-524. \[[PubMed: 31155730](https://pubmed.ncbi.nlm.nih.gov/31155730)\] 43. Padda IS, Chowdhury YS. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 25, 2023. Edoxaban. \[[PubMed: 33351434](https://pubmed.ncbi.nlm.nih.gov/33351434)\] 44. Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020 Feb 10;38(5):496-520. \[[PubMed: 31381464](https://pubmed.ncbi.nlm.nih.gov/31381464)\] 45. Li YK, Guo CG, Cheung KS, Liu KSH, Leung WK. Risk of Postcolonoscopy Thromboembolic Events: A Real-World Cohort Study. Clin Gastroenterol Hepatol. 2023 Nov;21(12):3051-3059.e4. \[[PubMed: 36167228](https://pubmed.ncbi.nlm.nih.gov/36167228)\] 46. Cheung KS, Leung WK. Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management. World J Gastroenterol. 2017 Mar 21;23(11):1954-1963. \[[PMC free article: PMC5360636](/pmc/articles/PMC5360636/)\] \[[PubMed: 28373761](https://pubmed.ncbi.nlm.nih.gov/28373761)\] 47. Nepal G, Kharel S, Bhagat R, Ka Shing Y, Ariel Coghlan M, Poudyal P, Ojha R, Sunder Shrestha G. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis. Acta Neurol Scand. 2022 Jan;145(1):10-23. \[[PubMed: 34287841](https://pubmed.ncbi.nlm.nih.gov/34287841)\] 48. Cohen AT, Hamilton M, Mitchell SA, Phatak H, Liu X, Bird A, Tushabe D, Batson S. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS One. 2015;10(12):e0144856. \[[PMC free article: PMC4696796](/pmc/articles/PMC4696796/)\] \[[PubMed: 26716830](https://pubmed.ncbi.nlm.nih.gov/26716830)\] 49. Cohen AT, Hamilton M, Bird A, Mitchell SA, Li S, Horblyuk R, Batson S. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and